Manhattan Scientifics, Inc. (MHTX)

Manhattan Scientifics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	-	-	0.05	0.05	0.05	0.1
Revenue Growth (YoY)	-	-	-	-	-48.45%	-
Gross Profit	-	-	0.05	0.05	0.05	0.1
Selling, General & Admin	0.67	0.69	0.72	0.73	0.71	1.11
Research & Development	0.01	0.01	0.01	0.01	0.01	0.01
Operating Expenses	0.68	0.7	0.73	0.74	0.73	1.12
Operating Income	-0.68	-0.7	-0.68	-0.69	-0.68	-1.03
Interest Expense	-	-	-0.02	-0.03	-0.03	-0.01
EBT Excluding Unusual Items	-0.68	-0.7	-0.7	-0.71	-0.7	-1.03
Gain (Loss) on Sale of Investments	-0.37	-0.48	-2.03	-2.97	5.01	-0.19
Other Unusual Items	-	0.02	-	0.05	-	-
Pretax Income	-1.06	-1.17	-2.73	-3.64	4.31	-1.22
Net Income	-1.06	-1.17	-2.73	-3.64	4.31	-1.22
Net Income to Common	-1.06	-1.17	-2.73	-3.64	4.31	-1.22
Shares Outstanding (Basic)	559	559	559	559	558	549
Shares Outstanding (Diluted)	559	559	559	559	593	549
Shares Change (YoY)	-	-	-	-5.69%	7.95%	2.92%
EPS (Basic)	-0.00	-0.00	-0.00	-0.01	0.01	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.01	0.01	-0.00
Free Cash Flow	-0.11	-0.19	-0.35	-0.42	-0.39	-0.32
Free Cash Flow Per Share	-	-	-0.00	-0.00	-0.00	-0.00
Gross Margin	-	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-	-1358.00%	-1374.00%	-1350.00%	-1056.70%
Profit Margin	-	-	-5460.00%	-7278.00%	8628.00%	-1259.79%
Free Cash Flow Margin	-	-	-698.00%	-842.00%	-784.00%	-325.77%
EBITDA	-0.68	-0.7	-0.68	-0.69	-0.67	-1.02
D&A For EBITDA	0	0	0	0	0	0
EBIT	-0.68	-0.7	-0.68	-0.69	-0.68	-1.03

Updated Aug 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.